Nikhil Lalwani, PRESIDENT & CEO at ANI PHARMACEUTICALS INC (ANIP), sold 5,400 shares at $74.30 ($401K) on 2026-08-25, disclosed to the SEC on 2026-08-26.
Scheduled sale ($401k) by PRESIDENT & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ANIP | SELL | 2026-05-13 | $4.3M | — | Filing → |
| ANIP | SELL | 2025-08-14 | $9.8M | — | Filing → |
| ANIP | SELL | 2024-11-27 | $2.1M | — | Filing → |